14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $84.38 $110.93 Friday, 3rd May 2024 BPMC stock ended at $107.19. This is 0.178% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.50% from a day low at $106.15 to a day high of $110.93.
90 days $72.25 $110.93
52 weeks $43.89 $110.93

Historical Blueprint Medicines Corporation prices

Date Open High Low Close Volume
Jun 18, 2020 $74.06 $76.81 $73.52 $76.32 258 676
Jun 17, 2020 $74.84 $76.33 $74.30 $74.68 266 822
Jun 16, 2020 $74.83 $76.17 $72.56 $74.42 276 671
Jun 15, 2020 $68.63 $73.08 $68.36 $73.03 405 956
Jun 12, 2020 $71.15 $71.42 $67.19 $69.89 368 471
Jun 11, 2020 $72.65 $73.10 $68.95 $69.07 464 887
Jun 10, 2020 $73.85 $75.86 $72.73 $74.17 366 799
Jun 09, 2020 $73.54 $75.25 $73.30 $73.45 370 815
Jun 08, 2020 $72.72 $74.52 $71.19 $74.30 373 789
Jun 05, 2020 $70.00 $72.65 $68.08 $71.17 422 753
Jun 04, 2020 $74.10 $74.89 $68.67 $69.51 655 635
Jun 03, 2020 $71.08 $74.92 $70.58 $74.53 927 509
Jun 02, 2020 $66.03 $70.80 $64.91 $70.72 604 246
Jun 01, 2020 $65.32 $67.25 $64.09 $66.24 515 454
May 29, 2020 $66.84 $67.28 $62.48 $65.14 822 813
May 28, 2020 $64.89 $68.00 $64.75 $66.99 602 643
May 27, 2020 $65.48 $65.48 $61.50 $64.31 648 113
May 26, 2020 $67.11 $68.39 $65.22 $65.32 470 972
May 22, 2020 $64.20 $65.26 $62.45 $65.18 524 780
May 21, 2020 $63.69 $65.34 $62.96 $64.60 334 722
May 20, 2020 $61.86 $63.59 $60.82 $63.49 513 357
May 19, 2020 $62.79 $63.37 $61.52 $61.57 290 169
May 18, 2020 $64.15 $65.84 $63.13 $63.31 662 315
May 15, 2020 $63.64 $65.29 $62.26 $63.58 685 368
May 14, 2020 $62.69 $64.60 $62.09 $64.28 553 664
Click to get the best stock tips daily for free!

About Blueprint Medicines Corporation

Blueprint Medicines Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advanced SM and other mast cell disorders; and Fisogatinib, an orally avail... BPMC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT